| Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice BA Rocha, EH Goulding, LE O'Dell, AN Mead, NG Coufal, LH Parsons, ... Journal of Neuroscience 22 (22), 10039-10045, 2002 | 208 | 2002 |
| The predictive validity of the rat self-administration model for abuse liability EC O’Connor, K Chapman, P Butler, AN Mead Neuroscience & Biobehavioral Reviews 35 (3), 912-938, 2011 | 207 | 2011 |
| The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking … EC O’Connor, D Parker, H Rollema, AN Mead Psychopharmacology 208, 365-376, 2010 | 128 | 2010 |
| Selective disruption of stimulus-reward learning in glutamate receptor gria1 knock-out mice AN Mead, DN Stephens Journal of Neuroscience 23 (3), 1041-1048, 2003 | 113 | 2003 |
| Increased vulnerability to self-administer cocaine in mice prenatally exposed to cocaine BA Rocha, AN Mead, BE Kosofsky Psychopharmacology 163, 221-229, 2002 | 80 | 2002 |
| Involvement of AMPA receptor GluR2 subunits in stimulus-reward learning: evidence from glutamate receptor gria2 knock-out mice AN Mead, DN Stephens Journal of Neuroscience 23 (29), 9500-9507, 2003 | 78 | 2003 |
| Reinstatement of cocaine seeking in 129X1/SvJ mice: effects of cocaine priming, cocaine cues and food deprivation DA Highfield, AN Mead, JW Grimm, BA Rocha, Y Shaham Psychopharmacology 161, 417-424, 2002 | 72 | 2002 |
| The concordance between nonclinical and phase I clinical cardiovascular assessment from a cross-company data sharing initiative L Ewart, M Aylott, M Deurinck, M Engwall, DJ Gallacher, H Geys, P Jarvis, ... Toxicological Sciences 142 (2), 427-435, 2014 | 71 | 2014 |
| AMPA‐receptor involvement in c‐fos expression in the medial prefrontal cortex and amygdala dissociates neural substrates of conditioned activity and conditioned reward AN Mead, A Vasilaki, C Spyraki, T Duka, DN Stephens European Journal of Neuroscience 11 (11), 4089-4098, 1999 | 71 | 1999 |
| Effects of deletion of gria1 or gria2 genes encoding glutamatergic AMPA-receptor subunits on place preference conditioning in mice AN Mead, G Brown, J Le Merrer, DN Stephens Psychopharmacology 179, 164-171, 2005 | 67 | 2005 |
| CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors AN Mead, DN Stephens Journal of Pharmacology and Experimental Therapeutics 290 (1), 9-15, 1999 | 66 | 1999 |
| Intravenous cocaine induced‐activity and behavioural sensitization in norepinephrine‐, but not dopamine‐transporter knockout mice AN Mead, BA Rocha, DM Donovan, JL Katz European Journal of Neuroscience 16 (3), 514-520, 2002 | 63 | 2002 |
| AMPA-receptor GluR1 subunits are involved in the control over behavior by cocaine-paired cues AN Mead, D Zamanillo, N Becker, DN Stephens Neuropsychopharmacology 32 (2), 343-353, 2007 | 61 | 2007 |
| Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials AN Mead, HR Amouzadeh, K Chapman, L Ewart, A Giarola, SJ Jackson, ... Regulatory Toxicology and Pharmacology 80, 348-357, 2016 | 58 | 2016 |
| Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABAA receptor positive allosteric modulator PF … SA Nickolls, R Gurrell, G van Amerongen, J Kammonen, L Cao, AR Brown, ... British journal of pharmacology 175 (4), 708-725, 2018 | 52 | 2018 |
| A translational pharmacology approach to understanding the predictive value of abuse potential assessments DB Horton, DM Potter, AN Mead Behavioural pharmacology 24 (5 and 6), 410-436, 2013 | 51 | 2013 |
| AMPA-receptors are involved in the expression of amphetamine-induced behavioural sensitisation, but not in the expression of amphetamine-induced conditioned activity in mice AN Mead, DN Stephens Neuropharmacology 37 (9), 1131-1138, 1998 | 51 | 1998 |
| Behavioural effects of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse A Jackson, AN Mead, DN Stephens Pharmacology & therapeutics 88 (1), 59-76, 2000 | 44 | 2000 |
| AMPA receptors and motivation for drug: effect of the selective antagonist NBQX on behavioural sensitization and on self-administration in mice A Jackson, AN Mead, BA Rocha, DN Stephens Behavioural pharmacology 9 (5), 457-467, 1998 | 42 | 1998 |
| Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior TT Wager, RY Chandrasekaran, J Bradley, D Rubitski, H Berke, S Mente, ... ACS Chemical Neuroscience 5 (12), 1253-1265, 2014 | 38 | 2014 |
